Fatal hyperacute graft-versus-host disease following denileukin diftitox treatment for recurrent t cell lymphoma after allogeneic stem cell transplantation.
Khubchandani
Sapna
S
Deeb
George
G
Smiley
Shannon L
SL
Battiwalla
Minoo
M
Paplham
Pamela
P
Brown
Karen
K
Syta
Margaret
M
Hahn
Theresa
T
Cheney
Richard
R
McCarthy
Philip L
PL
Hong
Frederick
F
D000208:Acute Disease; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D004167:Diphtheria Toxin / Q000008:administration & dosage*; D017809:Fatal Outcome; D006086:Graft vs Host Disease / Q000188:drug therapy*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage*; D016399:Lymphoma, T-Cell / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage; D014184:Transplantation, Homologous
D000970:Antineoplastic Agents; D004167:Diphtheria Toxin; D007376:Interleukin-2; D011993:Recombinant Fusion Proteins; C078456:denileukin diftitox